Media Center

Illustration of people examining large charts and graphs

Learn More

Johnson & Johnson Reports Q2 2022 Results

STELARA^® (ustekinumab) Approved by the U.S. Food and Drug Administration to Treat Pediatric Patients with Active Psoriatic Arthritis

Janssen Receives Positive CHMP Opinion for Novel Bispecific Antibody TECVAYLI^® (teclistamab) for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma (RRMM)

Janssen Announces U.S. FDA Breakthrough Therapy Designation Granted for Talquetamab for the Treatment of Relapsed or Refractory Multiple Myeloma

Latest Press Releases

Media Statement

August 11, 2022

Johnson & Johnson Consumer Health to Transition Global Baby Powder Portfolio to Cornstarch

Latest News

August 09, 2022

Johnson & Johnson to Participate in the Morgan Stanley 20^th Annual Global Healthcare Conference

Latest News

August 08, 2022

Mathai Mammen, M.D., Ph.D., Leaves Position as Executive Vice President, Pharmaceuticals, R&D, Johnson & Johnson

Latest News

August 04, 2022

European Commission Approves IMBRUVICA^® (ibrutinib) in a Fixed-Duration Combination Regimen for Adult Patients with Previously Untreated Chronic Lymphocytic Leukaemia (CLL)

Latest News

August 02, 2022

Johnson & Johnson to Participate in the 2022 Wells Fargo Securities Healthcare Conference

Latest News

August 01, 2022

STELARA^® (ustekinumab) Approved by the U.S. Food and Drug Administration to Treat Pediatric Patients with Active Psoriatic Arthritis

See All Press Releases

In the Media?

Sign up for Johnson & Johnson company news and press releases delivered right to your inbox.

Sign Up
Contact Media Relations

September 21, 2016

Thank you for your interest in learning more about our company. We care about your questions and concerns.

Contact Us

J&J Fast Facts

Our Company

We Work All Over the World

We have over 134,000 employees working across more than 260 operating companies located in 60 countries around the world.

Get to know Johnson & Johnson

See All Fast Facts

Social Media

Addressing pressing challenges in healthcare today takes collaboration. That's why #JNJ and @HCAhealthcare are work… https://t.co/4nkzqtdfnC

JNJNews
RT @JNJGlobalHealth: The fund will support efforts to scale and strengthen community health systems across Africa by training 200K #CHWs by…

JNJNews
The challenges health workers face have grown more complex and urgent than ever. #JNJ has joined forces with… https://t.co/yPW9iBlvQP

JNJNews

More From Johnson & Johnson

ON NOW

A view of a doctor from behind, as they look at brain scans

Innovation

The Quest to Make Neurodegenerative Disease a Thing of the Past

Imagine reversing the course of conditions like Alzheimer's or multiple sclerosis, in which cells of the central nervous system stop working or die. Researchers at Johnson & Johnson are hot on the trail of innovative solutions that may do just that, preventing often-debilitating symptoms along the way.

ON NOW

Our Heritage

136 Years of Championing Women's Health

Supporting the well-being of people around the world is a tenet that underscores all the work the company does. From must-have educational manuals to cutting-edge contraception, explore how Johnson & Johnson has been advocating for women's health since the company's inception more than a century ago.

ON NOW

Innovation

What it Takes to Truly Diversify Clinical Trials

What do diseases like multiple myeloma and lupus have in common? They're more prevalent in people of color—yet historically these patients have been left out of clinical research, often to dire health consequences. Learn how Johnson & Johnson is working to make the study of conditions like these more equitable.

Internet Explorer is no longer supported by this website.

Media Center

Latest Press Releases

J&J Fast Facts

Social Media

More From Johnson & Johnson